Mike Sathekge

225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

Mike Sathekge, Frank Bruchertseifer, Otto Knoesen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 344 citations · Full text

Medicine, Oncology, Pharmacology +17

Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients

Frederik L. Giesel, Clemens Kratochwil, Joel Schlittenhardt et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 215 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving ²²⁵Ac-PSMA-617 Radioligand Therapy

Mike Sathekge, Frank Bruchertseifer, Mariza Vorster et al. · Journal of Nuclear Medicine · 2019 · 194 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

68Ga-FAPI-PET/CT in patients with various gynecological malignancies

Katharina Dendl, Stefan A. Koerber, Rebecca Finck et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 178 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study

Mike Sathekge, Ismaheel O. Lawal, Chandrasekhar Bal et al. · The Lancet Oncology · 2024 · 178 citations

Medicine, Oncology, Urology +17